The screening of children for clinical trials of Covaxin will start at AIIMS in Delhi from today, days after similar trials started at AIIMS in Patna.
AIIMS Delhi will conduct clinical trials of the COVID-19 vaccine made by Bharat Biotech to see if it is suitable for children between two and 18 years old.
#Covid19 #Covaxin #ClinicalTrialsForChildren